GlassScriptPhysician profile
Peter L Kok
NPI 1538423496
$9,845.30
in general payments reported to CMS, 2019-2025
11 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2021: $4,083 · 2022: $3,722 · 2023: $174 · 2024: $1,430 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,053 · Food and Beverage: $760 · Education: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,052.64 |
| Food and Beverage | $759.53 |
| Education | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $4,494.12 | 2021-2023 | |
| Arthrex, INC. | $3,283.36 | 2019-2022 | |
| Stryker Corporation | $1,616.03 | 2023-2025 | Iconix, Salvation, Mako |
| Ferring Pharmaceuticals INC. | $131.30 | 2019-2024 | Euflexxa |
| Encore Medical, LP | $75.28 | 2019 | |
| Bioventus LLC | $56.21 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $51.03 | 2021-2022 | |
| Depuy Synthes Sales INC. | $44.03 | 2023-2024 | Monovisc, Orthovisc |
| Vericel Corporation | $40.37 | 2022-2025 | Maci |
| Vertex Pharmaceuticals Incorporated | $39.20 | 2025 | |
| Fidia Pharma USA INC. | $14.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.